AU6402996A - Delayed ripening tomato plants - Google Patents
Delayed ripening tomato plantsInfo
- Publication number
- AU6402996A AU6402996A AU64029/96A AU6402996A AU6402996A AU 6402996 A AU6402996 A AU 6402996A AU 64029/96 A AU64029/96 A AU 64029/96A AU 6402996 A AU6402996 A AU 6402996A AU 6402996 A AU6402996 A AU 6402996A
- Authority
- AU
- Australia
- Prior art keywords
- fruit
- plant
- tomato
- sequence
- stage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000003768 Solanum lycopersicum Species 0.000 title claims description 71
- 230000005070 ripening Effects 0.000 title description 17
- 230000003111 delayed effect Effects 0.000 title description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 72
- 241000196324 Embryophyta Species 0.000 claims description 52
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 39
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 21
- 239000005977 Ethylene Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 101100268668 Caenorhabditis elegans acc-2 gene Proteins 0.000 claims description 16
- 230000002068 genetic effect Effects 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 108091023045 Untranslated Region Proteins 0.000 claims 2
- 239000012634 fragment Substances 0.000 description 42
- 239000000523 sample Substances 0.000 description 29
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 22
- 108700019146 Transgenes Proteins 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 13
- 238000003780 insertion Methods 0.000 description 12
- 230000037431 insertion Effects 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 11
- 108091026890 Coding region Proteins 0.000 description 9
- 229930027917 kanamycin Natural products 0.000 description 9
- 229960000318 kanamycin Drugs 0.000 description 9
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 9
- 229930182823 kanamycin A Natural products 0.000 description 9
- 238000012217 deletion Methods 0.000 description 8
- 230000037430 deletion Effects 0.000 description 8
- 101710194665 1-aminocyclopropane-1-carboxylate synthase Proteins 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000004345 fruit ripening Effects 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 108010058731 nopaline synthase Proteins 0.000 description 6
- 101150092526 accs gene Proteins 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 241000701489 Cauliflower mosaic virus Species 0.000 description 4
- 241000146226 Physalis ixocarpa Species 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- PSOZMUMWCXLRKX-UHFFFAOYSA-N 2,4-dinitro-6-pentan-2-ylphenol Chemical compound CCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O PSOZMUMWCXLRKX-UHFFFAOYSA-N 0.000 description 3
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010025815 Kanamycin Kinase Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000010165 autogamy Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000005204 segregation Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 240000007377 Petunia x hybrida Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- UGJQDKYTAYNNBH-UHFFFAOYSA-N amino cyclopropanecarboxylate Chemical compound NOC(=O)C1CC1 UGJQDKYTAYNNBH-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008618 cell wall macromolecule catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8249—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving ethylene biosynthesis, senescence or fruit development, e.g. modified tomato ripening, cut flower shelf-life
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
Delayed Ripening Tomato Plants
BACKGROUND OF THE INVENTION
The present invention relates generally to the breeding of tomato plants. More specifically, the invention relates to the introduction of a transgene that confers a delayed ripening phenotype on tomato plants.
The plant hormone ethylene has a profound influence on plant physiology.
Active in trace amounts, it affects a number of processes such as fruit ripening, seed germination, plant growth, leaf and flower senescence, pathogen infection, and the interaction of plants with their environment. In particular, ethylene induces a number of physiological changes associated with fruit ripening such as accumulation of carotenoid pigments, conversion of cholorplasts to chromoplasts, the increased expression of genes encoding cell wall degradation enzymes, fruit softening and susceptibility to pathogens.
Control of the effects of ethylene is a particularly useful approach to controlling fruit ripening in tomato. More than 80% of tomatoes (by volume) currently sold in the United States are picked while green. Growers harvest green tomatoes for several reasons: (1) green tomatoes are firmer, enabling them to withstand shipping and handling with less injury; (2) a green tomato harvest is less labor-intensive and less costly than a vine-ripe harvest and (3) green fruit stays in the field for a shorter period of time reducing the risk of loss from weather or pests.
After harvest, either the packer or the repacker exposes the green tomatoes to an external source of ethylene gas to cause the tomatoes to develop red color. This practice reddens the fruit, but these tomatoes will not always develop full flavor when picked at the green stage. Fruit that have begun to ripen need to be shipped at a low temperature to delay ripening, however these low temperatures decrease fruit quality. Frequently, a portion of the green fruit is harvested at the immature green stage, which means that it will never achieve full ripeness even with the application of ethylene. Such tomatoes, together with other distribution-damaged tomatoes, do not achieve full flavor potential and, we believe, are a major factor contributing to consumer dissatisfaction with current fresh market tomatoes.
In tomato (and other so called climacteric fruit), fruit ripening is associated with a burst of respiration and a concomitant increase in ethylene production. Once ripening is initiated, the endogenous ethylene production rises autocatalytically.
If ethylene production could be controlled, tomato fruit could be left on the vine longer to develop the fruit components which contribute to flavor. The present invention addresses these and other needs.
SUMMARY OF THE INVENTION
The present invention provides tomato plants comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1. The plants bear fruit that display significant ripening impairment once the breaker stage is reached. In particular, the fruit reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15 °C. Preferred plants are germinated from seed deposited with the American Type Culture Collection under Accession No.
.
The invention further provides tomato fruit from the plants of the invention. The fruit of the invention have ethylene levels less than about 1.0 nl/g/hr, preferably less than about 0.5 nl/g/hr.
The invention also provides methods of tomato plants with decreased ethylene production. The methods comprise crossing a parent tomato plant with a tomato plant comprising a genetic locus of the invention. The tomato plant comprising the genetic locus can be a plant germinated from seed deposited with American Type Culture
Collection under Accession No.
. The method may further comprise the step of selecting progeny bearing fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
Definitions
The phrase "nucleic acid sequence" refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. It includes both self-replicating plasmids, infectious polymers of DNA or RNA and non-functional DNA or RNA.
The term " tomato plant" includes whole tomato plants, tomato plant organs (e.g. , leaves, stems, roots, etc.), seeds and tomato plant cells and progeny of same.
A tomato plant is "derived from" seed or another plant, if it is germinated directly from the seed or is progeny of the plant or seed (e.g. , F1, F2. etc.) as a result of
standard sexual reproduction.
A "primary transformant" is a plant regenerated from one or more plant cells transformed in vitro with a recombinant DNA construct.
A "heterologous sequence" is one that originates from a foreign species, or, if from the same species, is substantially modified from its original form. For example, a heterologous promoter operably linked to structural gene is from a species different from that from which the structural gene was derived, or, if from the same species, is different from the promoter normally present with the gene, or is substantially modified from its original form.
Two nucleic acid sequences or polypeptides are said to be "identical" if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The term
"complementary to" is used herein to mean that the sequence is complementary to all or a portion of a reference polynucleotide sequence.
Sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a "comparison window" to identify and compare local regions of sequence similarity. A "comparison window", as used herein, refers to a segment of at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned.
Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman Adv. Appl. Math. 2: 482 (1981), by the homology alignment algorithm of Needleman and Wunsch J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson and Lipman Proc. Natl. Acad. Sci. (U.S.A.) 85: 2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), 575 Science Dr. , Madison, WI), or by inspection. These references are incorporated herein by reference.
"Percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e. , gaps) as compared to the reference sequence (which does not comprise additions or
deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
The term "substantial identity" of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 60% sequence identity, preferably at least 80%, more preferably at least 90% and most preferably at least 95% , compared to a reference sequence using the programs described above (preferably BESTFIT) using standard parameters. One of skill will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning and the like. Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 40% , preferably at least 60% , more preferably at least 90%, and most preferably at least 95% .
Another indication that nucleotide sequences are substantially identical is if two molecules hybridize to each other under stringent conditions. Stringent conditions are sequence dependent and will be different in different circumstances. Generally, stringent conditions are selected to be about 5° C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Typically, stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60°C.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a schematic diagram of the T-DNA region of
pWTT2144/AccS.
Figure 2 is a restriction map of the T-DNA region of pWTT2144/AccS showing the location of the hybridization probes used in the genomic mapping.
Figure 3 is a schematic diagram showing the Acc2 genomic region and Acc2 cDNA and the fragments used as probes to determine transgene structure in the 1345-4 transformant.
Figure 4 is schematic diagram showing the structure of the T-DNA insert of the invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention provides tomato plants (Lycopersicon esculentum) comprising a stably incorporated locus that confers a delayed fruit ripening phenotype on the plant. In particular, the tomato plants of the invention contain a T-DNA insert comprising a sequence (the AccS transgene) derived from a tomato fruit-specific aminocyclopropane carboxylate (ACC) synthase gene, but that does not encode a functional ACC synthase enzyme.
ACC synthase is the rate limiting enzyme that converts s- adenosylmethionine to 1-aminocyclopropane-1-carboxylic acid, the immediate precursor to ethylene. As explained in detail below, incorporation of the AccS transgene in a tomato plant genome inhibits expression of the ACC synthase gene. Inhibition of ACC synthase biosynthesis results in reduced levels of ethylene biosynthesis. Thus, fruit of tomato plants comprising the transgene exhibit a delayed ripening phenotype, but ripen normally when external ethylene is applied.
As used herein an "AccS transgene" is a truncated coding region from the tomato Acc2 gene which is fused to a 35S promoter from cauliflower mosaic virus and a nos3 ' termination sequence from Agrobacterium tumefaciens. In particular, the sequence from the Acc2 gene is a sequence consisting of nucleotide 149 to nucleotide 1237.
Rottman et al. J. Mol. Biol. 222:937-961 (1991).
The plants of the invention are derived, directly or indirectly, from transformation of a tomato plant cell with a construct comprising a T-DNA having the following regions: (1) LB, the left border region of Agrobacterium T-DNA; (2) 2χpnos, a tandem duplicate untranslated promoter region of the nopaline synthase gene from Agrobacterium; (3) nptll, the neomycin phosphotransferase gene from Tn5; (4) ocs3' , the 3' untranslated genion of the octopine synthase gene from Agrobacterium; (5) LacZ' , an untranslated LacZ polylinker sequence; (6) p35S, the 35S promoter form cauliflower mosaic virus (7) Cab22L, the leader sequence corresponding to the 5' untranslated region of the Cab22R gene from petunia fused to the 35S promoter; (8) AccS, the truncated coding region from base 149 to base 1237 of the tomato Acc2 gene; (9) nos 3' , the untranslated 3' region of the nopaline synthase gene from Agrobacterium; and (10)
RB, a right border region of Agrobacterium T-DNA.
The "T-DNA insert" of the invention comprises three copies of the T- DNA described above. The three copies are arranged in inverted repeats at the LB and RB. At the LB-LB and RB-RB junction, one border is deleted such that there is only one complete border at each junction. The LB and RB at either end of the T-DNA structure are also deleted.
An exemplary plasmid comprising the T-DNA described above, pWTT2144/AccS, is described in detail below. This plasmid is used to generate transgenic tomato plants using Agrobacterium tumefaciens-mediated transformation techniques. Stable insertion of the AccS transgene into the tomato genome in the sense orientation can result in down-regulation of expression of the corresponding endogenous Acc2 gene and a reduction in ethylene biosynthesis in the ripening fruit. The technique is an example of Transwitch™ suppression (U.S. Patent No. 5,283, 184). One feature of Transwitch™ gene suppression is the reduced accumulation of the targeted gene mRNA (reduced steady state RNA). The trait (level of suppression), once selected through the first sexual generation, behaves in a simple Mendelian fashion.
The methods of the present invention can be used to delay fruit ripening of any tomato (large fruited or cherry) cultivar for fresh market or processing tomato production. Exemplary cultivars that can be used include essentially all commercial cultivars. For listings of suitable tomatoes see, Rick, in Evolution of Crop Plants N.W. Simmonds, ed. pp268-273 (Longman, London, 1976) and Taylor in The Tomato Crop pp1-35 (Chapman and Hall, London, 1986).
A tomato plant of the present invention can be obtained by crossing a plant comprising the T-DNA insert of the invention with any tomato cultivar lacking the insert. Any standard method used for crossing tomato plants can be used to introduce the transgene into the genome of the desired plant. Generally, the methods involve emasculation of one parent, followed by application of pollen from the other parent to the stigma of the first parent. The crosses can be performed using either parent as the pollen parent. Embryo rescue can also be performed if the flowers abort after
pollination.
The plant containing the T-DNA insert can be a plant derived from primary transformants or can be a plant in which the factor was introduced through a sexual cross. Preferred plants of the invention are those derived from seed deposited
with the American Type Culture Collection (ATCC) Accession No. .
A number of methods can be used to determine if a tomato plant exhibiting a delayed ripening phenotype comprises the T-DNA insert of the invention in its genome. The terms used herein to describe ripeness of tomato fruit are according to standard ripeness classes as described, for instance, in The Tomato Crop Atherton and Rudich eds. (Chapman Hall, 1986). The ripeness classes for a given given fruit are set forth in Table 1.
Fruit of the plants of the invention reach breaker stage between about 40 and about 70 days after anthesis, usually between about 45 and about 60 days after anthesis. The fruit, however, differ significantly from wild type fruit in terms of ripening inhibition. On the vine, the fruit of plants of the invention typically remain at the breaker stage 5 to 7 days longer than wild type. The transition from breaker stage to light red stage in the ripening impaired fruit is further delayed with respect to the transition for wild type fruit. Under field conditions the fruit of the invention typically require approximately 21 days to proceed from the breaker stage to light red stage, whereas wild type fruit typically require 4 to 5 days to turn from the breaker stage to the red stage. The ripening impaired fruit under field conditions can remain indefinitely at the light red stage without ever reaching the red stage.
There are analogous differences in ripening for off the vine fruit picked at the breaker stage and stored at 15°C. Ripening impaired fruit of the invention typically require at least about 2 weeks (typically about 3 weeks) to reach the pink stage, and while some may reach the light red stage, the fruit can remain indefinitely without
reaching the red stage. Fruit will, however, reach the red stage upon the application of ethylene. This is to be contrasted with wild type fruit which typically require 5 to 7 days to reach red ripe stage from the breaker stage under comparable conditions.
Fruit color development, as measured by the a/b ratio measures about 5 to about 10 fold less in the fruit of the invention as compared to control fruit at the breaker or equivalent stage. Standard methods for determining tomato fruit color are described, for instance, in Gull et al. J. Amer. Soc. Hon. Sci. 114:950-954 (1989) and Kader et al. Hort. Sci. 13:577-578 (1978). At the time the control fruit are red ripe, the levels of color in the fruit of the invention are 4 to 5 times lower.
In addition, the fruit do not synthesize normal levels of ethylene during ripening. Typically, the level which is detected at the breaker or equivalent stage is less than about 0.5 nl/g/hr, usually about 0.1 nl/g/hr as measured using a standard assay as described in Grierson and Tucker, Planta 157: 174-179 (1983) and Sawamura et al. Plant Cell Physiol. 19: 1061-1069 (1978). At the pink stage which follows the breaker stage the fruit continue to have ethylene levels which are reduced by about 50 to about 100 fold compared to control fruit.
Since the T-DNA inserts comprise NPTII genes, kanamycin resistance can be determined using selective media or by spraying 10- 14 day old tomato seedlings with a solution of kanamycin (Ig/L) on three consecutive days. The levels of Acc2 mRNA can be measured using standard techniques such as Northern blots, RNAse protection assays and the like. To further characterize the plants nucleic hybridization techniques can be used to determine structure of the T-DNA insert in the plant. The example section, below, provides a detailed description of the molecular characterization of the T-DNA insert of the invention.
The precise locus in which the T-DNA insert of the invention is integrated can be determined using standard genetic and molecular mapping techniques well known to those of skill in the art. Obviously, for plants derived either directly or indirectly from a particular plant or seed containing the T-DNA insert (e.g. , those deposited with the ATCC under Accession No.
), the locus will be the same as the parent plant.
The following example is provided to illustrate, but not limit the claimed invention.
Example 1
A. Agrobacterium- mediated transformation system
Introduction of DNA into plant tissue by Agrobacterium-mediated transformation as described in U.S. Patent No. 5,283, 184. The vector system used to transfer the AccS transgene into tomato is based on the Ti plasmid from Agrobacterium tumefaciens.
The T-DNA plasmid, pWTT2144/AccS, used in these transformations is composed of: (1) the replication of origin from pACYC184 that ensures replication in Escherichia coli; (2) the pVS1 replicon (derived from Pseudomonas aeruginosa DNA) that ensures replication in A. tumefaciens; (3) the tetracycline resistance marker from plasmid RP1 that allows for selection of the binary plasmid in A. tumefaciens and E. coli, and (4) the left and right border regions of T-DNA from an octopine strain of A. tumefaciens which surround the DNA insertion in the plant genome.
Within the T-DNA are the nptII gene from transposon Tn5 that encodes enzyme neomycin phosphotransferase II and serves as a selectable marker for
transformed plant cells, fused to a nopaline synthase (nos) promoter sequence and octopine synthase (ocs3 ') termination sequence from A. tumefaciens, and the LacZ' polylinker region with multiple restriction sites for cloning of genes to be transferred. The T-DNA has an insertion of a truncated Acc2 gene coding region fused to the 35S promoter from cauliflower mosaic virus and the nos3 ' termination sequence in the LacZ' polylinker region of pWTT2144.
Plasmid pWTT2144 was transferred from E. coli to A. tumefaciens
LBA4404, which carries the pAL4404 vir plasmid, by a triparental mating procedure as described by Figurski et al. , Proc. Natl. Acad. Sci. USA 76: 1648-1652 (1979).
The plasmid pWTT2144/ AccS was used to transform the parental line 91 103-114 to generate line 1345-4, described in detail below. The T-DNA region of this plasmid consists of the following sequences (see, Figure 1):
CaMV35S. The 35S promoter region is derived from cauliflower mosaic virus and controls expression of the AccS gene. The 35S promoter directs high level constitutive expression and is widely used as a promoter for high expression of transgenes.
Cab22L leader. The Cab22L leader sequence (Cab22L) is a 69 bp fragment of Petunia hybrida genomic DNA which was derived from the Cab22L gene and corresponds to the 5' untranslated region for that gene.
AccS. The AccS gene is a truncated coding region derived from an ACC
synthase gene (Acc2) isolated from tomato (L. esculentum). The AccS gene corresponds to a 1088 bp region of the Acc2 gene from base 149 to base 1237. The AccS gene does not encode a functional ACC synthase enzyme.
Termination sequences. The nopaline synthase (nos3 ') and octopine synthase (ocs3 ') gene termination sequences from A. tumefaciens function in the expression of the AccS and nptII genes, respectively.
2Xpnos Promoter. The nos promoter is present in line 1345-4 as a duplicate tandem repeat of the untranslated 5' region of the nopaline synthase gene from A. tumefaciens. It functions in line 1345-4 in the expression of the nptII selectable marker gene. This sequence, as used in line 1345-4, no longer functions as a regulated article since it is not associated with the nopaline synthase coding region which functions in A. tumefaciens.
Nptll. The nptII gene is a coding region originally isolated from transposon Tn5. It encodes a protein, neomycin phosphotransferase II, which catalyzes the phosphorylation of certain aminoglycoside antibiotics, rendering transformed cells resistant to kanamycin. It functions in line 1345-4 as a selectable marker.
LacZ' polylinker sequence. The untranslated LacZ' polylinker sequence functions in line 1345-4 as a site for cloning the AccS transgene into the binary vector pWTT2144. Borders. The left and right border regions of T-DNA from A. tumefaciens function in the transfer of gene sequences into the tomato genome. The border regions are the only necessary m-acting elements in T-DNA for T-DNA insertion. The use of a binary vector system allows for other necessary transfer elements to act in trans so that only the border regions are required to be integrated into the plant host genome. The T-DNA borders are only partially transferred to the tomato genome; during the transformation process, the left border is cut between nucleotides 293 and 294 (left border nick) while the right border is cut between nucleotides 7603 and 7604 (right border nick). This cleavage reduces the length of the right border fragment of pWTT2144/AccS from 1900 bp to 303 bp in the T-DNA and the left border fragment of pWTT2144/AccS from 880 bp to 589 bp in the T-DNA (Figure 1).
B. Description of Non-transformed Tomato Cultivar 91103-114
DNAP tomato line 91103-114 is a somaclone derived from the breeding line FL7181 developed by Dr. Jay Scott at the University of Florida. Line FL7181 is characterized as a determinate large-fruited variety with an average fruit weight of 8 oz.
Fruit are globate to slightly elliptical in shape and are substantially firmer than fruit of comparable varieties (i.e. , Floradade). Fruit shoulders are smooth and exhibit a darker green shade than the rest of the fruit surface before ripening. Fruit ripen to a deep crimson red interior color due to the presence of the ogc allele. The fruit stem (pedicel) lacks a joint. This line is known to be resistant to Verticillium wilt race 1 and Fusarium wilt races 1 and 2.
The DNAP line 91103-1 14 exhibits all of the traits described above, but differs from FL7181 principally by reduced blossom end scar size, strong main stem and increased foliage cover for fruit. Line 91103-1 14 also differs from FL7181 in its adaptation to diverse growth environments; while FL7181 is specifically adapted to Florida growing regions, 91 103-114 has proven to grow well in other regions (e.g. , California).
C. Description, History and Mendelian Inheritance of Delayed-Ripening Tomato Line 1345-4
The line 1345-4 is a homozygous T2 selection from an original T0 transformant 1345, obtained after Agrobacterium tumefaciens transformation of the DNAP line 91103-114 with binary vector pWTT2144/ AccS.
The primary transformant 1345 was selected in a greenhouse screen of several hundred primary transformants to have fruit which did not ripen when left on the vine. Subsequently, 10 of the 1345 T, seed (derived from self fertilization) which were prescreened for kanamycin resistance were sceened in the greenhouse and observations on the plant and fruit phenotype were made. Plant 1345-4 was selected as having fruit which did not ripen on the vine. The 1345-4 plant was shown to be homozygous for the T-DNA locus. Seed from the self-fertilization of 1345-4 have been subsequently analyzed in multiple field trials over multiple growing seasons.
No instability in the delayed-ripening phenotype has been observed in any field trials. Two independent ways have been used to monitor the stability of line 1345-4. First, it is possible to establish that the T-DNA insertion is stable and intact by measuring kanamycin resistance in large populations of seedlings in the greenhouse. It was established that the 1345 plant was carrying a single T-DNA insertion by evaluating the segregation of kanamycin resistance in the primary transformant. Subsequently, multiple kanamycin-resistant T2 plants were selected and segregation of the
kanamycin-resistant phenotype in progeny plants arising from self-fertilization of the
selected T2 plants was evaluated. The T3 plants from 1345-4 were all kanamycin resistant, hence it was deduced that the 1345-4 plant was homozygous.
The second approach to evaluating the stability of line 1345-4 is through observation of the delayed-ripening phenotype in the field. A number of separate field trials for the evaluation of the homozygous 1345-4 line and progeny derived from it have been carried out. These trials have involved the evaluation of fruit on at least 2000 separate plants of 1345-4. During these evaluations, which involved observations of the individual plants at multiple times during the ripening process and the harvest of fruit from all of the plants, no exceptional plants in which all the fruit ripen at the normal rate have been observed.
D. DNA Analysis of Delayed-Ripening Tomato Line 1345-4
To determine the nature and number of insertions which have occurred in line 1345, Southern hybridizations were used to characterize the structure of the T-DNA inserts in the genomic DNA, in conjunction with the nptII segregation data described above which indicates the T-DNA locus number. The T-DNA is defined as the region between the left and right borders of the binary vector pWTT2144/AccS that is transferred into the plant (see Figure 1). This region includes the nptII selectable marker and the truncated ACC synthase gene (AccS), together with the left and right border sequences. Figure 2 shows the restriction enzymes used to cleave the DNA and the location of the four probes used to determine the structure of T-DNA insert, the left border (LB), nptII, Acc2, and right border (RB) probes.
1. Copy number
The number of additional AccS genes in 1345 was determined by digesting genomic DNA from transgenic plants with HindIII and EcoRI. then after electrophoresis and transfer to nylon membranes, hybridizing to a 32P-labeled Acc2 probe. This probe hybridizes to a 0.9 kb EcoRI-HindIII fragment from the transgene (AccS) and a 1.2 kb HindIII fragment from the endogenous Acc2 gene which includes an additional 300 bp of intron sequence. By comparing the intensity of the transgene and endogenous bands, a determination of the number of copies of the transgene can be made in either the hemizygous primary transformant or homozygous S1 progeny. The hybridization patterns of genomic DNA from an untransformed tomato plant, Baxter's Early Bush Cherry (BEB) and 1345-4 digested with HindIII and EcoRI and hybridized to the Acc2 probe were analyzed. In 1345-4, the homozygous S1 progeny of 1345, the
endogenous gene to transgene ratio is greater than 2 suggesting that there are at least 2 copies of AccS in the transgenic DNA. Since the nptII gene segregates as a single locus, it is most probable that the 2-3 copies of the T-DNA are present at a single locus.
2. T-DNA Structure
It is known that a single intact copy or multiple T-DNA copies can be inserted at a single locus as direct or inverted repeats around either the left or right border, and it is known that deletions of the T-DNA or insertions of genomic DNA may be present between the T-DNA copies (Jorgenson et al , Mol. Gen. Genet. 207:471-477 (1987)). To determine the organization of the T-DNAs in the 1345 genome, we hybridized several different probes to the 1345-4 genome digested with several restriction enzymes. Figure 2 shows the relative map position of the probes in the T-DNA.
Left and Right Borders: Eco-RI digestions were done to determine the number of intact left and right border fragments. EcoRI sites in the T-DNA are located approximately 500 bp in from the LB and 2.1 kb in from the RB (within the AccS transgene). The fragments hybridizing to the specific border probe will be at least this size. If there is an inverted repeat at the LB and the borders are intact and flush, we would expect to see a 1 kb EcoRI fragment hybridizing only to the LB. For the RB, an intact inverted repeat would give a 4.2 kb fragment that hybridizes to the RB fragment as well as to the AccS probe. A direct LB-RB repeat would result in a fragment of 2.6 kb that hybridizes to both border probes and AccS.
In 1345-4 DNA cut with EcoRI, a 2.9 kb fragment hybridizes to the LB probe only and a 3.5 kb fragment hybridizes to the RB probe only, indicating that there is one intact left and right border. Likewise, the NcoI digestions show single hybridizing bands with both probes and the fragments are of appropriate sizes (LB fragment, greater than 1.6 kb and RB fragment greater than 2.3 kb). The HindIII and XbaI digests also show single bands of appropriate sizes which suggests that there is a single complete T-DNA insertion. However, we know from the copy number blots (see above) that there are at least two copies of the AccS transgene. Together these results suggest that a deleted form of T-DNA, containing an intact AccS gene but missing one or both of the borders, is also present. There are no direct repeat structures since the LB and RB probes do not hybridize to the same fragment. There could, however, be inverted or indirect repeats around either border. Hybridizations with the nptII and AccS probes were done to further characterize the T-DNA insertions.
nptII: If the T-DNA is intact, the nptII probe will hybridize to a single 2.4 kb EcoRI fragment containing the entire 2Xpnos-nptII-ocs3' fusion (see Figure 2). In 1345-4 genomic DNA cut with EcoRI, the expected 2.4 kb fragment is present in addition to two other hybridizing fragments of 5.2 kb and 2.9 kb. The 2.9 kb fragment also hybridizes to the left border probe which indicates that there is probably one complete internal copy and 2 incomplete copies of T-DNA with deletions occurring at the LB. Since the 2.9 kb EcoRI fragment hybridizes to both nptII and LB probes, this junction is likely an inverted repeat with a deletion of one of the borders that includes the EcoRI site. Hybridization of an EcoRI fragment to both the LB probe and the nptII probe can only occur if a deletion eliminates one of the EcoRI sites.
Since NcoI cleaves within the nptII coding sequence, digestion of the T-DNA with this enzyme will give two nptII fragments, one of 2.1 kb which spans the nptII 3' coding region up to the NcoI site located at the ATG of the AccS transgene, and one of 1.2 kb in length which includes the 5' nptII coding region and LB to the next NcoI site in either genomic DNA or adjacent T-DNA insertion. If there is a perfect inverted repeat at the LB, we expect a 3.3 kb NcoI fragment that hybridizes to both the nptII and LB probes. Based on the results from the EcoRI digestion, we expect the 2.1 kb fragment to be present, as well as two fragments greater than 1.2 kb. One of these will also hybridize to, the LB. As predicted, the 2.1 kb fragment is present as well as a 6.6 kb fragment and a 2.9 kb fragment which also hybridizes to the LB probe. This is consistent with the presence of three T-DNA copies, one which is complete and intact, one which is an inverted repeat with a deletion (approximately 600 bp) extending to the LB, and a second inverted repeat with a deletion (approximately 50 bp) extending to the right border.
AccS: Hybridization with the AccS probe will give fragments greater than
2.3 kb and 2.1 kb for NcoI and EcoRI digests respectively. These fragments will also hybridize to the RB probe if the border is intact. The results show two hybridizing fragments for NcoI, 15 kb and 3.8 kb, and two for EcoRI, 4 kb and 3.5 kb. The 3.8 kb NcoI fragment and the 3.5 kb EcoRI fragment also hybridize to the RB. These results confirm that there are at least 2 copies of AccS, and that one copy is present on a T-DNA with a deleted RB. To demonstrate that AccS itself has not been deleted or rearranged, NcoI/XbaI double digests were done to drop out the intact 1 .1 kb fragment containing the complete truncated gene.
Linkage of AccS and nptII: XbaI and HindIII cleave the T-DNA once approximately 1 kb in from the right border. Digestion with either of these enzymes will generate fragments containing both the nptII and AccS genes. After XbaI digestion, a 9.2 kb and a 6.2 kb fragment hybridized with both probes. After HindIII digestion, a 9.2 kb and 6.4 kb fragment hybridized to both probes confirming that each copy of AccS is linked to a copy of nptII. The 9.2 kb fragment also hybridizes to the LB. The size of the fragments are consistent with the presence of inverted T-DNA repeats at the LB and RB.
The structure for 1345-4 T-DNA insertion is shown in Figure 4. It consists of three T-DNAs assembled in inverted repeats at the LB and RB. At the LB-LB and
RB-RB junction, one border is deleted such that there is likely only one complete border at each junction. The LB and RB at either end of the T-DNA structure are also deleted. The endpoint rightward is internal to the nptII gene and deletes the internal NcoI site, and the endpoint leftward lies between the Acc2 gene and the right border.
Finally, the nucleotide sequence of the T-DNA insert of 1345-4 has been complied from the deduced restriction map and is present in SEQ. ID. No. 1.
The above examples are provided to illustrate the invention but not to limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference.
Claims (16)
1. A tomato plant comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1.
2. The plant of claim 1, wherein the plant bears fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
3. The plant of claim 1, wherein the fruit do not reach red stage in the absence of application of ethylene.
4. The plant of claim 1, which is germinated from seed deposited with the American Type Culture Collection under Accession No. .
5. A tomato fruit from the plant of claim 1.
6. A tomato fruit that reaches pink stage about 2 to about 3 weeks after breaker stage, when the fruit is picked at breaker stage and stored at 15 °C.
7. The tomato fruit of claim 6, wherein the fruit does not reach red stage in the absence of application of ethylene.
8. The tomato fruit of claim 6, wherein the fruit has an ethylene level less than about 1.0 nl/g/hr.
9. A method of making a tomato plant with decreased ethylene production, the method comprising:
crossing a parent tomato plant with a tomato plant comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1, thereby producing progeny.
10. The method of claim 9, wherein the tomato plant comprising the genetic locus is germinated from seed deposited with American Type Culture Collection under Accession No. .
11. The method of claim 9, further comprising the step of selecting comprises selecting progeny bearing fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
12. A plant made according to the method of claim 9.
13. A tomato plant comprising a genetic locus comprising: an inserted T-DNA, consisting essentially of, from the 5' to the 3' direction, a left border sequence, a 2Xpnos promoter sequence, an NPTII gene, an ocs3' untranslated region, a p35S promoter sequence, a sequence consisting of nucleotide 149 to nucleotide 1237 of a tomato Acc2 gene, a nos3' untranslated region, and a right border sequence;
a right border inverted repeat of the T-DNA linked to the right border sequence, the right border inverted repeat lacking a left and a right border sequence; and a left border inverted repeat linked to the left border sequence, the left border inverted repeat lacking a left and a right border sequence.
14. A tomato fruit from the plant of claim 13.
15. A tomato plant which is germinated from seed deposited with the American Type Culture Collection under Accession No. .
16. A tomato fruit from the plant of claim 15.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72195P | 1995-06-30 | 1995-06-30 | |
| US60/000721 | 1995-06-30 | ||
| PCT/US1996/011096 WO1997001952A1 (en) | 1995-06-30 | 1996-06-28 | Delayed ripening tomato plants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6402996A true AU6402996A (en) | 1997-02-05 |
| AU710874B2 AU710874B2 (en) | 1999-09-30 |
Family
ID=21692734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU64029/96A Ceased AU710874B2 (en) | 1995-06-30 | 1996-06-28 | Delayed ripening tomato plants |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0837624A1 (en) |
| JP (1) | JPH11510376A (en) |
| AU (1) | AU710874B2 (en) |
| CA (1) | CA2226088A1 (en) |
| MX (1) | MX9800118A (en) |
| WO (1) | WO1997001952A1 (en) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710475D0 (en) * | 1997-05-21 | 1997-07-16 | Zeneca Ltd | Gene silencing |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| WO1999049029A1 (en) | 1998-03-20 | 1999-09-30 | Benitec Australia Ltd | Control of gene expression |
| SI1068311T1 (en) † | 1998-04-08 | 2011-07-29 | Commw Scient Ind Res Org | Methods and means for obtaining modified phenotypes |
| US8598332B1 (en) | 1998-04-08 | 2013-12-03 | Bayer Cropscience N.V. | Methods and means for obtaining modified phenotypes |
| US20040214330A1 (en) | 1999-04-07 | 2004-10-28 | Waterhouse Peter Michael | Methods and means for obtaining modified phenotypes |
| CA2361201A1 (en) | 1999-01-28 | 2000-08-03 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
| US7485715B2 (en) | 1999-06-18 | 2009-02-03 | Ceres, Inc. | Sequence-determined DNA encoding AP2 domain polypeptides |
| US7479555B2 (en) | 1999-07-21 | 2009-01-20 | Ceres, Inc. | Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| CA2369944A1 (en) | 2001-01-31 | 2002-07-31 | Nucleonics Inc. | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
| US9758790B2 (en) | 2004-12-08 | 2017-09-12 | Ceres, Inc. | Modulating the level of components within plants |
| WO2007084926A2 (en) | 2006-01-17 | 2007-07-26 | Biolex Therapeutics, Inc. | Compositions and methods for humanization and optimization of n-glycans in plants |
| US8222482B2 (en) | 2006-01-26 | 2012-07-17 | Ceres, Inc. | Modulating plant oil levels |
| WO2007120989A2 (en) | 2006-02-24 | 2007-10-25 | Ceres, Inc. | Shade regulatory regions |
| US20130191941A1 (en) | 2006-07-05 | 2013-07-25 | Shing Kwok | Modulating light response pathways in plants, increasing light-related tolerances in plants, and increasing biomass in plants |
| US8362322B2 (en) | 2006-10-27 | 2013-01-29 | Ceres, Inc. | Modulating lignin in plants |
| US8222388B2 (en) | 2006-11-22 | 2012-07-17 | Ceres, Inc. | Broadly expressing regulatory regions |
| US8298794B2 (en) | 2008-10-09 | 2012-10-30 | Ceres, Inc. | Cinnamyl-alcohol dehydrogenases |
| WO2010046423A2 (en) | 2008-10-22 | 2010-04-29 | Basf Se | Use of sulfonylurea herbicides on cultivated plants |
| WO2010046422A2 (en) | 2008-10-22 | 2010-04-29 | Basf Se | Use of auxin type herbicides on cultivated plants |
| EA202091701A1 (en) | 2009-07-20 | 2021-01-29 | Серес, Инк. | INCREASE IN BIOMASS OF TRANSGENIC PLANTS |
| WO2011140329A1 (en) | 2010-05-06 | 2011-11-10 | Ceres, Inc. | Transgenic plants having increased biomass |
| BR112013010278B1 (en) | 2010-10-27 | 2020-12-29 | Ceres, Inc | method to produce a plant, method to modulate the biomass composition in a plant, isolated nucleic acid and method to alter the biomass composition in a plant |
| WO2012169969A1 (en) | 2011-06-10 | 2012-12-13 | Temasek Life Sciences Laboratory Limited | Genetic manipulation and expression systems for pucciniomycotina and us tilaginom ycotina subphyla |
| BR122020026837B1 (en) | 2011-11-02 | 2021-04-13 | Ceres, Inc | METHOD OF INCREASING PLANT Yield IN SOIL CONTAINING HIGH LEVELS OF AL3 +, METHOD OF INCREASING TOLERANCE IN A PLANT |
| US10323256B2 (en) | 2011-12-09 | 2019-06-18 | Ceres, Inc. | Transgenic plants having altered biomass composition |
| IN2014KN02312A (en) | 2012-04-19 | 2015-05-01 | Temasek Life Sciences Lab Ltd | |
| CA2886130C (en) * | 2012-09-28 | 2022-11-01 | Nunhems B.V. | Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene |
| JP2015532274A (en) | 2012-10-01 | 2015-11-09 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Use of N-thio-anthranilamide compounds in cultivated plants |
| WO2014079820A1 (en) | 2012-11-22 | 2014-05-30 | Basf Se | Use of anthranilamide compounds for reducing insect-vectored viral infections |
| US9101100B1 (en) | 2014-04-30 | 2015-08-11 | Ceres, Inc. | Methods and materials for high throughput testing of transgene combinations |
| CA3226788A1 (en) | 2014-07-15 | 2016-01-21 | Ceres, Inc. | Methods of increasing crop yield under abiotic stress |
| CN107002062A (en) | 2014-10-22 | 2017-08-01 | 淡马锡生命科学研究院有限公司 | Terpene synthase from Ylang ylang fruticosa var. (Cananga odorata var. fruticosa) |
| EP3028573A1 (en) | 2014-12-05 | 2016-06-08 | Basf Se | Use of a triazole fungicide on transgenic plants |
| WO2016091674A1 (en) | 2014-12-12 | 2016-06-16 | Basf Se | Use of cyclaniliprole on cultivated plants |
| BR112017021450B1 (en) | 2015-04-07 | 2021-12-28 | Basf Agrochemical Products B.V. | PEST CONTROL METHODS, PLANT HEALTH IMPROVEMENT METHOD AND COATED SEED |
| KR20190003504A (en) | 2016-03-24 | 2019-01-09 | 유니버시타이트 라이덴 | How to Transform Plants and Reduce Random Integration Events |
| EP3338552A1 (en) | 2016-12-21 | 2018-06-27 | Basf Se | Use of a tetrazolinone fungicide on transgenic plants |
| EP3502259A1 (en) | 2017-12-19 | 2019-06-26 | Universiteit Leiden | A combinational strategy for reducing random integration events when transfecting plants |
| US11473086B2 (en) | 2019-06-19 | 2022-10-18 | Ut-Battelle, Llc | Loss of function alleles of PtEPSP-TF and its regulatory targets in rice |
| NL2035852B1 (en) | 2023-09-21 | 2025-03-28 | Academisch Ziekenhuis Leiden | Enhancement of t cell mediated therapies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843186B1 (en) * | 1986-07-28 | 1997-02-25 | Lsl Inc | Long shelf life heterozygous tomato plant |
| US5231020A (en) | 1989-03-30 | 1993-07-27 | Dna Plant Technology Corporation | Genetic engineering of novel plant phenotypes |
-
1996
- 1996-06-28 AU AU64029/96A patent/AU710874B2/en not_active Ceased
- 1996-06-28 WO PCT/US1996/011096 patent/WO1997001952A1/en not_active Ceased
- 1996-06-28 JP JP9505241A patent/JPH11510376A/en active Pending
- 1996-06-28 EP EP96923543A patent/EP0837624A1/en not_active Ceased
- 1996-06-28 CA CA 2226088 patent/CA2226088A1/en not_active Abandoned
-
1997
- 1997-01-07 MX MX9800118A patent/MX9800118A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU710874B2 (en) | 1999-09-30 |
| JPH11510376A (en) | 1999-09-14 |
| CA2226088A1 (en) | 1997-01-23 |
| WO1997001952A1 (en) | 1997-01-23 |
| EP0837624A1 (en) | 1998-04-29 |
| MX9800118A (en) | 1998-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU710874B2 (en) | Delayed ripening tomato plants | |
| US6670526B1 (en) | Arabidopsis ESD4 gene and method to control flowering time | |
| US7166771B2 (en) | Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs | |
| AU718262B2 (en) | Methods and constructs for producing male sterile plants | |
| CN109134632B (en) | Protein for regulating and controlling plant root development and coding gene and application thereof | |
| US6162964A (en) | Molecular methods of hybrid seed production | |
| CA2281487A1 (en) | Leafy cotyledon1 genes and their uses | |
| WO1990008828A2 (en) | Molecular methods of hybrid seed production | |
| US5952546A (en) | Delayed ripening tomato plants with T-DNA bearing a truncated ACC2 synthase gene | |
| US20150007360A1 (en) | Method for plant improvement | |
| JPH08508412A (en) | Plants with modified response to ethylene | |
| EP3689895B1 (en) | Modulation of seed vigor | |
| WO2005079389A2 (en) | In vivo assembly of transcription units | |
| US5569831A (en) | Transgenic tomato plants with altered polygalacturonase isoforms | |
| CA2258571A1 (en) | Plant sterol reductases and uses thereof | |
| WO1997048793A9 (en) | Plant sterol reductases and uses thereof | |
| US6762347B1 (en) | NOR gene compositions and methods for use thereof | |
| WO2021003592A1 (en) | Sterile genes and related constructs and applications thereof | |
| AU2006314535A1 (en) | EMP4 gene | |
| HUT71783A (en) | Crucifer acc-synthase, gene coding it, the promoter of the gene, and recombinant methods for production of acc-synthase and transgenic plants expressing acc-synthase | |
| CA2226945A1 (en) | Method for expressing foreign genes and vectors therefor | |
| EP0814161A1 (en) | Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis | |
| US20060123514A1 (en) | Self-fertile apple resulting from S-RNAase gene silencing | |
| KR102695341B1 (en) | Method for producing transgenic pepper with flower-specific Cas9 expression for virus-induced gene editing, transgenic pepper with flower-specific Cas9 expression produced by the same method and uses thereof | |
| JP2001037358A (en) | Cotton plant having improved cotton fiber properties, method for producing the same, and method for producing cotton fiber from said cotton plant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |